We are live on ! Find out more
VMD icon

Viemed Healthcare

127 hedge funds and large institutions have $177M invested in Viemed Healthcare in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 62 increasing their positions, 34 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 34

1.89% more ownership

Funds ownership: 62.89%64.78% (+1.9%)

2% less capital invested

Capital invested by funds: $181M → $177M (-$3.97M)

9% less funds holding

Funds holding: 139127 (-12)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

50% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 22

Holders
127
Holders Change
-12
Holders Change %
-8.63%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
11
Increased
62
Reduced
34
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$33.3M +$8.2M +1,208,703 +33%
FCM
2
Forager Capital Management
Alabama
$14.8M +$1.57M +230,670 +12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$12.6M +$270K +39,842 +2%
Thrivent Financial for Lutherans
4
Thrivent Financial for Lutherans
Minnesota
$11.2M -$7.35M -1,083,000 -40%
WA
5
Wasatch Advisors
Utah
$10.7M +$1.63M +240,346 +18%
KLP
6
Kent Lake PR
Puerto Rico
$8.15M -$319K -46,975 -4%
NCM
7
Nantahala Capital Management
Connecticut
$6.44M
Geode Capital Management
8
Geode Capital Management
Massachusetts
$5.52M +$104K +15,353 +2%
Goldman Sachs
9
Goldman Sachs
New York
$5.24M +$31.1K +4,578 +0.6%
State Street
10
State Street
Massachusetts
$4.56M +$240K +35,373 +6%
PAIM
11
Punch & Associates Investment Management
Minnesota
$4.24M +$224K +33,000 +6%
First Eagle Investment Management
12
First Eagle Investment Management
New York
$3.15M +$204K +30,000 +7%
TAM
13
Tocqueville Asset Management
New York
$2.88M
Renaissance Technologies
14
Renaissance Technologies
New York
$2.84M +$176K +25,900 +7%
RA
15
Raffles Associates
New York
$2.78M
PM
16
Penbrook Management
New York
$2.75M +$1.22M +180,020 +87%
PAM
17
Panagora Asset Management
Massachusetts
$2.42M +$776K +114,323 +48%
BA
18
Bard Associates
Illinois
$2.32M -$90.2K -13,295 -4%
Morgan Stanley
19
Morgan Stanley
New York
$1.97M +$779K +114,718 +67%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$1.9M -$209K -30,756 -10%
Northern Trust
21
Northern Trust
Illinois
$1.86M -$94.8K -13,960 -5%
RHJA
22
Rice Hall James & Associates
California
$1.65M -$143K -21,126 -8%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$1.62M
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$1.47M +$596K +87,832 +70%
Russell Investments Group
25
Russell Investments Group
United Kingdom
$1.42M +$34.3K +5,051 +3%

VMD Hedge Fund Activity: Q2 2025 in Review

127 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q2 2025, worth a combined $177M — down 2.2% from $181M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VMD and 11 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 62 added.

The largest buyer was BlackRock, adding an estimated $8.2M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $7.35M.

  • 127 institutional investors held Viemed Healthcare (VMD) as of Q2 2025, down from 139 in Q1 2025.
  • Funds reported $177M of Viemed Healthcare stock for Q2 2025, down 2.2% quarter-over-quarter.
  • 11 funds opened new Viemed Healthcare positions in Q2 2025 and 22 closed out, a net change of -11 holders.
  • The largest Viemed Healthcare buyer in Q2 2025 was BlackRock, an estimated $8.2M added.
  • The largest Viemed Healthcare seller in Q2 2025 was Thrivent Financial for Lutherans, an estimated $7.35M sold.

Based on aggregated 13F filings for Q2 2025.